Peter Salzmann - May 16, 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Sean Moran, attorney-in-fact for Peter Salzmann
Stock symbol
CRBP
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/20/2024, 05:00 PM
Previous filing
Apr 19, 2024
Next filing
May 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option (right to buy) Award $0 +2.78K $0.00 2.78K May 16, 2024 Common Stock 2.78K $45.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.